183 companies

Trulieve Cannabis

Market Cap: US$1.8b

Operates as a cannabis retailer in the United States.

TRLV

US$9.60

7D

6.7%

1Y

18.4%

High Tide

Market Cap: CA$285.6m

Engages in the cannabis retail business in Canada, the United States, and internationally.

HITI

CA$3.24

7D

0.9%

1Y

-7.7%

CorMedix

Market Cap: US$557.0m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

CRMD

US$8.14

7D

8.4%

1Y

-35.4%

Hypera

Market Cap: R$15.4b

Operates as a pharmaceutical company in Brazil.

HYPE3

R$21.84

7D

1.1%

1Y

-4.3%

Innovent Biologics

Market Cap: HK$163.3b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.

1801

HK$93.80

7D

-1.1%

1Y

-3.8%

Elanco Animal Health

Market Cap: US$11.1b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

ELAN

US$22.51

7D

-7.0%

1Y

25.1%

Green Thumb Industries

Market Cap: CA$2.2b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

GTII

CA$10.28

7D

7.1%

1Y

-12.8%

Hugel

Market Cap: ₩2.8t

Develops and manufactures biopharmaceuticals in South Korea and internationally.

A145020

₩256,000.00

7D

-6.4%

1Y

-19.2%

Yunnan Baiyao GroupLtd

Market Cap: CN¥89.3b

Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.

000538

CN¥50.03

7D

-1.4%

1Y

-10.6%

UCB

Market Cap: €41.8b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

UCB

€212.30

7D

-4.8%

1Y

10.3%

Prestige Consumer Healthcare

Market Cap: US$2.5b

Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.

PBH

US$51.32

7D

-5.7%

1Y

-20.6%

Bavarian Nordic

Market Cap: DKK 14.0b

Develops, manufactures, and supplies life-saving vaccines.

BAVA

DKK 185.60

7D

5.2%

1Y

-21.9%

Dong-E-E-Jiao

Market Cap: CN¥33.1b

Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.

000423

CN¥51.92

7D

-2.8%

1Y

3.2%

Diaceutics

Market Cap: UK£122.7m

A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.

DXRX

UK£1.44

7D

-5.9%

1Y

4.7%

Virbac

Market Cap: €2.8b

Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Pacific.

VIRP

€332.50

7D

-3.6%

1Y

0.5%

Decibel Cannabis

Market Cap: CA$66.4m

An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.

DB

CA$0.12

7D

9.5%

1Y

-4.2%

Cresco Labs

Market Cap: CA$484.0m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

CL

CA$1.10

7D

7.8%

1Y

-19.7%

Fennec Pharmaceuticals

Market Cap: US$414.5m

Operates as a commercial stage biopharmaceutical company in the United States.

FENC

US$12.06

7D

11.3%

1Y

41.4%

Journey Medical

Market Cap: US$177.0m

A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

DERM

US$6.65

7D

1.8%

1Y

-8.4%

Tarsus Pharmaceuticals

Market Cap: US$3.1b

A commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.

TARS

US$68.88

7D

5.4%

1Y

27.2%

Dong-A ST

Market Cap: ₩371.1b

Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.

A170900

₩38,500.00

7D

0.7%

1Y

-12.2%

Duopharma Biotech Berhad

Market Cap: RM 1.2b

Researches, develops, manufactures, markets, sells, imports, and distributes pharmaceutical products and medicines in Malaysia and internationally.

DPHARMA

RM 1.25

7D

1.6%

1Y

-3.8%

Amoy Diagnostics

Market Cap: CN¥7.5b

Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.

300685

CN¥19.53

7D

8.4%

1Y

-18.3%

Perrigo

Market Cap: US$1.8b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

PRGO

US$12.83

7D

2.3%

1Y

-44.3%

China Resources Pharmaceutical Group

Market Cap: HK$30.4b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

3320

HK$4.85

7D

0.1%

1Y

-8.4%

United Laboratories International Holdings

Market Cap: HK$17.2b

An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.

3933

HK$8.72

7D

-5.5%

1Y

-45.4%

Daewoong Pharmaceutical

Market Cap: ₩1.4t

Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.

A069620

₩124,600.00

7D

-3.4%

1Y

-7.0%

Dermapharm Holding

Market Cap: €2.0b

Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.

DMP

€39.60

7D

-2.2%

1Y

21.1%

Laboratorios Farmaceuticos Rovi

Market Cap: €3.0b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

ROVI

€57.95

7D

-0.7%

1Y

2.7%

Viatris

Market Cap: US$18.5b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

VTRS

US$16.04

7D

-1.5%

1Y

50.0%

Verastem

Market Cap: US$629.4m

A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.

VSTM

US$6.67

7D

12.9%

1Y

-13.7%

Vanda Pharmaceuticals

Market Cap: US$313.8m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

VNDA

US$5.03

7D

-1.7%

1Y

13.5%

Madrigal Pharmaceuticals

Market Cap: US$12.4b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

MDGL

US$507.37

7D

-0.6%

1Y

36.6%

Abeona Therapeutics

Market Cap: US$425.2m

A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.

ABEO

US$6.35

7D

-8.0%

1Y

-12.2%

ARS Pharmaceuticals

Market Cap: US$600.8m

A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally.

SPRY

US$6.10

7D

9.9%

1Y

-57.8%

Amphastar Pharmaceuticals

Market Cap: US$849.9m

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

AMPH

US$20.18

7D

1.9%

1Y

-33.2%

Page 1 of 6